Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership with global green chemistry education nonprofit Beyond Benign.

KB-707 by Krystal Biotech for Solid Tumor: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 28, 2023

Tennessee Medical Board Refuses to Enforce New IMG Law

Members of the Tennessee Board of Medical Examiners felt they were locked in an impossibly tough spot. They had to choose between defying a new

September 7, 2024

Numinus Wellness Submits Clinical Trial Application | Psychedelic Invest

VANCOUVER, BC, March 20, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.